ZOE.LSE · Zoetic International Plc
-
-
| Exchange | LSE |
|---|---|
| CurrencyCode | GBP |
| ISIN | None |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Beta | 1.53 |
|---|---|
| Market Cap | 80M |
| PE Ratio | None |
| Target Price | None |
| Dividend Yield | None |
ABOUT
Zoetic International Plc
Zoetic International Plc, a vertically integrated CBD company, researches, develops, produces, and sells cannabidiol (CBD) consumer products and other hemp derivatives in the United States and the United Kingdom. The company offers oral CBD tinctures and CBD gummies, as well as softgel, massage oil, and skincare products. Its CBD products are used for pharmaceutical and tobacco replacement applications. The company was formerly known as Highlands Natural Resources plc and changed its name to Zoetic International Plc in September 2019. Zoetic International Plc was founded in 2014 and is headquartered in London, the United Kingdom.
Learn More